Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people

Nutrition Journal

Joshua Bomser¹  Shi Zhao¹  Elizabeth Joseph¹  Robert A DiSilvestro¹ 

[1] Department of Human Nutrition, The Ohio State University, 345 Campbell Hall, 1787 Neil Ave, Columbus, OH, 43210-1295, USA

关键词: Antioxidant activity;    Antioxidant capacity;    Nitric oxide;    Catalase;    Curcumin;   

Others  :  823937
DOI  :  10.1186/1475-2891-11-79

 received in 2012-07-24, accepted in 2012-09-21,  发布年份 2012

【 摘 要 】

Background

Curcumin extracts of turmeric are proposed to produce health benefits. To date, human intervention studies have focused mainly on people with existing health problems given high doses of poorly absorbed curcumin. The purpose of the current study was to check whether in healthy people, a low dose of a lipidated curcumin extract could alter wellness-related measures.

Methods

The present study was conducted in healthy middle aged people (40–60 years old) with a low dose of curcumin (80 mg/day) in a lipidated form expected to have good absorption. Subjects were given either curcumin (N = 19) or placebo (N = 19) for 4 wk. Blood and saliva samples were taken before and after the 4 weeks and analyzed for a variety of blood and saliva measures relevant to health promotion.

Results

Curcumin, but not placebo, produced the following statistically significant changes: lowering of plasma triglyceride values, lowering of salivary amylase levels, raising of salivary radical scavenging capacities, raising of plasma catalase activities, lowering of plasma beta amyloid protein concentrations, lowering of plasma sICAM readings, increased plasma myeloperoxidase without increased c-reactive protein levels, increased plasma nitric oxide, and decreased plasma alanine amino transferase activities.

Conclusion

Collectively, these results demonstrate that a low dose of a curcumin-lipid preparation can produce a variety of potentially health promoting effects in healthy middle aged people.

【 授权许可】

   
2012 DiSilvestro et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Strimpakos A, Sharma R: Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Food Chem Toxicol 2008, 10:511-545.
• [2]Epstein J, Sanderson I, Macdonald T: Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 2010, 103:1545-1557.
• [3]Naik S, Thakare V, Patil S: Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: evidence of its antioxidant property. Exp Toxicol Pathol 2011, 63:419-431.
• [4]Yang K, Lin L, Tseng T, Wang S, Tsai T: Oral bioavailability of curcumin in rat and the herbal analysis from curcuma Longa by LC-MS/MS. J Chromatogr B Analy Technol Biomed Life Sci 2007, 853:183-189.
• [5]Vareed S, Kakarala M, Ruffin M, et al.: Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008, 17:1411-1417.
• [6]Bisht S, Maitra A: Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr Drug Discov Technol 2009, 6:192-199.
• [7]Khajehdehi P, Pakfetrat M, Javidnia K, et al.: Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol 2011, 45:365-370.
• [8]Pungcharoenkul K, Thongnopnua P: Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects. Phytother Res 2011, 25:1721-1726.
• [9]Durgaprasad S, Pai CG, Vasanthkumar Alvres JF, Namitha S: A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res 2005, 122:315-318.
• [10]Sugawara J, Akazawa N, Miyaki A, et al.: Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study. Am J Hypertens 2012. in press
• [11]Arafa H: Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 2005, 11:BR228-BR234.
• [12]Rukkumani R, Aruna K, Varma P, Rajasekaran K, Menon V: Comparative effects of curcumin and its analog on alcohol- and polyunsaturated fatty acid-induced alterations in circulatory lipid profiles. J Med Food 2005, 8:256-260.
• [13]Yiu W, Kwan P, Wong C, et al.: Attenuation of fatty liver and prevention of hypercholesterolemia by extract of curcuma Longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase. J Food Sci 2011, 76:H80-H89.
• [14]Aftab N, Vieira A: Antioxidant activities of curcumin and combinations of this curcuminoid with other phytochemicals. Phytother Res 2010, 24:500-502.
• [15]Iqbal M, Sharma S, Okazaki Y, Fujisawa M, Okada S: Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 2003, 92:33-38.
• [16]Kempaiah R, Srinivasan K: Antioxidant status of red blood cells and liver in hypercholesterolemic rats fed hypolipidemic spices. Int J Vitam Nutr Res 2004, 74:199-208.
• [17]Thresiamma K, George J, Kuttan R: Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol 1996, 34:845-847.
• [18]Eybl V, Kotyzova D, Koutensky J: Comparative study of natural antioxidants curcumin, resveratrol and melatonin - in cadmium-induced oxidative damage in mice. Toxicology 2006, 225:150-156.
• [19]Ataie A, Sabetkasaei M, Haghparast A, Moghaddam A, Kazeminejad B: Neuroprotective effects of the polyphenolic antioxidant agent, curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat. Pharmacol Biochem Behav 2010, 96:378-385.
• [20]Zhang C, Browne A, Child D, Tanzi R: Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J Biol Chem 2010, 285:28472-28480.
• [21]Hamaguchi T, Ono K, Yamada M: Curcumin and Alzheimer's disease. CNS Neurosci Ther 2010, 16:285-297.
• [22]DiSilvestro RA, Marten JT: Effects of inflammation and copper intake on rat liver and erythrocyte Cu-Zn superoxide dismutase activity levels. J Nutr 1990, 120:1223-1227.
• [23]Hirooka Y, Kishi T, Sakai K: Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension. Am J Physiol Regul Integr Comp Physiol 2011, 300:R818-R826.
• [24]Tang W, Pankow JS, Carr JJ: Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study. BMC Cardiovasc Disord 2007, 7:30. BioMed Central Full Text
• [25]Nauseef WM: How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007, 219:88-102.
• [26]Zhang R, Brennan ML, Fu X: Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001, 286:2136-2142.
• [27]Calabrò P, Golia E, Yeh E: CRP and the risk of atherosclerotic events. Semin Immunopathol 2009, 31:79-94.
• [28]Rohleder N, Nater U: Determinants of salivary alpha-amylase in humans and methodological considerations. Psychoneuroendocrinology 2009, 34:469-485.
• [29]Moro M, Collins M, Cappellini E: Alzheimer's disease and amyloid beta-peptide deposition in the brain: a matter of 'aging'? Biochem Soc Trans 2010, 38:539-544.
• [30]Craxı A, Almasio P: Diagnostic approach to liver enzyme elevation. J Hepatol 1996, 25S:47-51.
• [31]Nanji AA, Jokelainen K, Tipoe G, Rahemtulla A, Thomas P, Dannenberg AJ: Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kB-dependent genes. Am J Physiol Gastrointest Liver Physiol 2003, 284:G321-G327.
• [32]Almeida JA, Riordan SM, Liu J, Galhenage S, Kim R, Bihari D, Wegner EA, Cranney GB, Thomas PS: Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome. Eur J Gastroenterol Hepatol 2007, 19:341-346.
• [33]Girish C, Koner B, Jayanthi S, Ramachandra Rao K, Rajesh B, Pradhan S: Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice. Fundam Clin Pharmacol 2009, 23:735-745.
• [34]Balaji S, Chempakam B: Toxicity prediction of compounds from turmeric (curcuma Longa L). Food Chem Toxicol 2010, 48:2951-2959.
• [35]Baum L, Cheung SK, Mok VC, Lam LC, Leung VP, Hui E, Ng CC, Chow M, Ho PC, Lam S, Woo J, Chiu HF, Goggins W, Zee B, Wong A, Mok H, Cheng WK, Fong C, Lee JS, Chan MH, Szeto SS, Lui VW, Tsoh J, Kwok TC, Chan IH, Lam CW: Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol Res 2007, 56:509-514.
• [36]Srivastava R, Singh S, Dubey S, Misra K, Khar A: Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol 2011, 11:331-341.
• [37]Ak T, Gülçin I: Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008, 174:27-37.
• [38]Ramos MP, Madrigal MJ, Martinez PR, et al.: Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2011, 31:3011-3019.
• [39]Biswas J, Sinha D, Mukherjee S, Roy S, Siddiqi M, Roy M: Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal. Hum Exp Toxicol 2010, 29:513-524.